Facebook
Twitter
Telegram
Fehler meldenEledon Pharmaceuticals Bilanz 2011-2024 | ELDN
Bilanz Jährlich Eledon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-55.7 M | -84.1 M | -114 M | -8.47 M | -13 M | -17.2 M | -23.2 M | -24 M | -105 M | -31.8 M | -11.7 M | - | |
Langfristige Schulden |
- | 383 K | 400 K | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
383 K | 363 K | 369 K | 144 K | 180 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 144 K | - | - | 84 K | 88 K | - | 85.3 M | 49.8 M | - |
Kurzfristige Verbindlichkeiten |
3.9 M | 6.48 M | 4.4 M | 2.48 M | 1.32 M | - | - | 2.82 M | 6.16 M | 4.24 M | - | - | - |
Gesamtverbindlichkeiten |
5.65 M | 8.61 M | 6.55 M | 6.59 M | 1.47 M | 2.53 M | 1.44 M | 2.9 M | 6.25 M | 4.24 M | 87.6 M | 51.9 M | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-243 M | -203 M | -115 M | - | -57.6 M | -41.6 M | -27.5 M | -169 M | -131 M | -86.4 M | -63.1 M | -47.3 M | - |
Vermögenswerte |
89.1 M | 92.8 M | 171 M | 197 M | 10.9 M | 17 M | 20.9 M | 29.8 M | 68 M | 108 M | 32.3 M | 12 M | - |
Zahlungsmittel |
4.61 M | 56.4 M | 84.8 M | 114 M | 8.79 M | 13 M | 17.2 M | 23.2 M | 24 M | 105 M | 31.8 M | 11.7 M | - |
Buchwert |
83.4 M | 84.2 M | 164 M | 191 M | 9.46 M | 14.5 M | 19.5 M | 26.9 M | 61.7 M | 104 M | -55.3 M | -39.9 M | - |
Gesamtes Eigenkapital |
83.4 M | 84.2 M | 164 M | 191 M | 9.46 M | 14.5 M | 19.5 M | -2.7 M | 61.7 M | 104 M | -55.3 M | -39.9 M | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Eledon Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | 83 K | 184 K | 284 K | 383 K | 461 K | 299 K | 350 K | 400 K | 45 K | 90 K | - | - | - | 48 K | 97 K | 144 K | 144 K | 144 K | 144 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 94 K | 245 K | 48 K | 84 K | 120 K | 156 K | - | 88 K | 88 K | 88 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
6 M | 5.65 M | 4.73 M | 6.84 M | 7.51 M | 8.61 M | 8.49 M | 5.33 M | 5.06 M | 6.55 M | 6.42 M | 5.78 M | 7.81 M | 6.59 M | 6.59 M | 6.59 M | 6.59 M | 1.47 M | 1.47 M | 1.47 M | 1.47 M | 2.53 M | 2.53 M | 2.53 M | 2.53 M | 1.44 M | 1.44 M | 1.44 M | 1.44 M | 3.9 M | 3.9 M | 3.9 M | 2.9 M | 6.25 M | 6.25 M | 6.25 M | 6.25 M | 4.24 M | 4.24 M | 4.24 M | 4.24 M | 2.21 M | 2.21 M | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-253 M | -243 M | -234 M | -223 M | -214 M | -203 M | -144 M | -134 M | -125 M | -115 M | -106 M | -96.3 M | -88.9 M | -80.4 M | -80.4 M | -80.4 M | -80.4 M | -57.6 M | -57.6 M | -57.6 M | -57.6 M | -41.6 M | -41.6 M | -41.6 M | -41.6 M | -27.5 M | -27.5 M | -27.5 M | -27.5 M | -14.4 M | -14.4 M | -14.4 M | -169 M | -131 M | -131 M | -131 M | -131 M | -86.4 M | -86.4 M | -86.4 M | -86.4 M | -63.1 M | -63.1 M | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
80.8 M | 89.1 M | 96.1 M | 107 M | 82.3 M | 92.8 M | 150 M | 155 M | 161 M | 171 M | 177 M | 184 M | 192 M | 197 M | 197 M | 197 M | 197 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 17 M | 17 M | 17 M | 17 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 1.2 M | 1.2 M | 1.2 M | 29.8 M | 68 M | 68 M | 68 M | 68 M | 108 M | 108 M | 108 M | 108 M | 32.3 M | 32.3 M | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
5.66 M | 4.61 M | 3.67 M | 40.9 M | 46.5 M | 56.4 M | 65.9 M | 70.5 M | 76.7 M | 84.8 M | 94 M | 101 M | 109 M | 114 M | 114 M | 114 M | 114 M | 8.79 M | 8.79 M | 13.7 M | 8.79 M | 13 M | 16.3 M | 13 M | 13 M | 17.2 M | 19.1 M | 22.5 M | 24.4 M | 1.1 M | 1.1 M | 1.1 M | 23.2 M | 24 M | 24 M | 24 M | 24 M | 105 M | 105 M | 105 M | 105 M | 31.8 M | 31.8 M | - | - | 11.7 M | - | - | - | 2.25 M | - | - | - |
Buchwert |
74.8 M | 83.4 M | 91.3 M | 99.9 M | 74.8 M | 84.2 M | 141 M | 149 M | 156 M | 164 M | 171 M | 179 M | 184 M | 191 M | 191 M | 191 M | 191 M | 9.46 M | 9.46 M | 9.46 M | 9.46 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M | -2.7 M | -2.7 M | -2.7 M | 26.9 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 104 M | 104 M | 104 M | 104 M | 30.1 M | 30.1 M | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
74.8 M | 83.4 M | 91.3 M | 99.9 M | 74.8 M | 84.2 M | 141 M | 149 M | 156 M | 164 M | 171 M | 179 M | 184 M | 191 M | 191 M | 191 M | 191 M | 9.46 M | 9.46 M | 9.46 M | 9.46 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M | -2.7 M | -2.7 M | -2.7 M | 26.9 M | 2.78 M | 61.7 M | 61.7 M | 61.7 M | 104 M | 104 M | 104 M | 104 M | -55.3 M | -55.3 M | - | - | -39.9 M | - | - | - | -30.4 M | - | - | - |
Alle Zahlen in USD-Währung